The Hemfosa share

The company’s ordinary share was listed on Nasdaq Stockholm, Mid Cap, on March 21, 2014 under the ticker symbol “HEMF.” The company’s preference share was listed on Nasdaq Stockholm, Mid- Cap, on December 12, 2014 under the ticker symbol “HEMF PREF.” On January 2, 2017, trading in the company’s ordinary shares and preference shares was moved to Nasdaq Stockholm Large Cap.

On June 19, 2018, Hemfosa carried out a directed share issue comprising 10,000,000 ordinary shares. On account of the directed share issue, the company increased its share capital by SEK 5,000,000, which thereafter amounts to SEK 89,364,124. The company received a capital infusion totaling MSEK 1,085 before issue expenses.

At March 31, 2019, Hemfosa had 27,286 shareholders.